文献速递遗传性与小管间质肾病水电解质与酸碱

自身免疫性肾小管病

Autoimmune Tubulopathies.
PubMed 文献 · J Am Soc Nephrol · 2025-01-09

本文综述了自身免疫性肾小管病的现有认识,按肾小管受累节段分类:近端小管可致抗刷状缘抗体病、肾范可尼综合征、近端肾小管酸中毒或小管间质性肾炎伴葡萄膜炎综合征;亨氏袢升支粗段可致获得性Bartter综合征或低镁血症伴高钙尿症;远端小管可致获得性Gitelman综合征;集合管可致远端肾小管酸中毒或肾性尿崩症。作者认为此类疾病可能被低估,多数自身抗体特征及发病机制尚不明确,呼吁提高认识并加强研究。

要点

  • 自身免疫性肾小管病按受累节段分类:近端小管、亨氏袢升支粗段、远端小管、集合管。
  • 近端小管自身抗体可致抗刷状缘抗体病、肾范可尼综合征、近端肾小管酸中毒或小管间质性肾炎伴葡萄膜炎综合征。
  • 亨氏袢升支粗段自身抗体可致获得性Bartter综合征或低镁血症伴高钙尿症;远端小管可致获得性Gitelman综合征;集合管可致远端肾小管酸中毒或肾性尿崩症。

核心结论

  • 自身免疫性肾小管病可能被低估,多数自身抗体特征及发病机制尚不明确,需提高认识和加强研究。

研究设计与样本

  • 综述,总结当前关于自身免疫性肾小管病的知识,按靶向肾小管节段分类。

主要发现

  • 近端小管自身抗体可致抗刷状缘抗体病、肾范可尼综合征、近端肾小管酸中毒或小管间质性肾炎伴葡萄膜炎综合征。
  • 亨氏袢升支粗段自身抗体可致获得性Bartter综合征或低镁血症伴高钙尿症。
  • 远端小管自身抗体可致获得性Gitelman综合征。
  • 集合管自身抗体可致远端肾小管酸中毒或肾性尿崩症。
  • 多数情况下自身抗体特征不完整,疾病发病机制不明。

临床怎么用

  • 提高对自身抗体介导的肾小管疾病的认识,以更好估计患病率并改善患者护理。

局限性

  • 多数自身抗体特征不完整,发病机制不明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The renal tubule and collecting duct express a large number of proteins, all having putative immunoreactive motives. Therefore, all can be the target of pathogenic autoantibodies. However, autoimmune tubulopathies seem to be rare, and we hypothesize that they are underdiagnosed. This review summarizes the current knowledge on autoimmune tubulopathies. We elected to classify tubulopathies according to the segment that is targeted because this determines, at least in part, the phenotypic presentation. In the proximal tubule, autoantibodies can cause anti-brush border antibody disease, renal Fanconi syndrome, renal proximal tubular acidosis, or tubulointerstitial nephritis and uveitis syndrome. Autoantibodies targeting the thick ascending limb of the loop of Henle can cause either acquired Bartter syndrome or hypomagnesemia with hypercalciuria, whereas autoantibodies targeting the distal convoluted tubule can cause acquired Gitelman syndrome. Finally, renal distal tubular acidosis or nephrogenic diabetes insipidus can be caused by autoantibodies targeting the collecting duct. In most instances, the characterization of the autoantibodies remains incomplete and the pathogenesis of the disease obscure. We believe it is important to increase the awareness of physicians regarding autoantibody-mediated tubular diseases to have a better estimation of the prevalence and to improve the care to patients. A research effort to increase the understanding of the pathogenesis of autoantibodies-mediated tubular diseases is also hoped for.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Houillier P, Prot-Bertoye C. Autoimmune Tubulopathies. J Am Soc Nephrol. 2025. PMID: 39786900. doi:10.1681/ASN.0000000628

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。